RA

Ram Avtar Singh

Director Director DIN 00555489
DIN 00555489 First appointment Jan 2001 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Jan 2001
Shareholding value •••• Premium profile

About Ram Avtar Singh

Data last updated:

Ram Avtar Singh was a Director at Arbro Pharmaceuticals Private Limited (2001–2009) and Director at Auriga Research Private Limited (2007–2009). The companies operate in Pharma.

DIN 00555489
Primary Designation Director
Industry Pharma
First Appointment 19 Jan 2001

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director19 Jan 20011985₹64.16 Cr (FY 2025)Active
Auriga Research Private Limited U74899DL1994PTC063731
Director01 Mar 20071994₹59.48 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Arbro Pharmaceuticals Private Limited
Auriga Research Private Limited
Premium access

Shareholding and investment profile for Ram Avtar Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ram Avtar Singh

Ram Avtar Singh was first appointed on 19 Jan 2001 as Director at Arbro Pharmaceuticals Private Limited. The most recent appointment on record is 01 Mar 2007 at Auriga Research Private Limited.

Ram Avtar Singh held 2 earlier board appointments: Arbro Pharmaceuticals Private Limited (Director, 19 Jan 2001 to 01 Aug 2009); Auriga Research Private Limited (Director, 01 Mar 2007 to 01 Aug 2009).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available